Evaluation of an oral direct anti-Xa anticoagulant, apixaban, for the prevention of venous thromboembolism in patients with myeloma treated with IMiD* compounds: A pilot study (MYELAXAT). (Record no. 72021)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00615cam a2200181 4500 |
| 001 - CONTROL NUMBER | |
| control field | CN99461 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120401t2017 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0732183X |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Brigitte Pegourie |
| 240 ## - UNIFORM TITLE | |
| Uniform title | <a href="Journal of Clinical Oncology">Journal of Clinical Oncology</a> |
| 245 ## - TITLE STATEMENT | |
| Title | Evaluation of an oral direct anti-Xa anticoagulant, apixaban, for the prevention of venous thromboembolism in patients with myeloma treated with IMiD* compounds: A pilot study (MYELAXAT). |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 8019-8019 |
| 500 ## - GENERAL NOTE | |
| General note | Serial |
| 500 ## - GENERAL NOTE | |
| General note | 7156034 |
| 500 ## - GENERAL NOTE | |
| General note | 35 |
| 500 ## - GENERAL NOTE | |
| General note | https://doi.org/10.1200/JCO.2017.35.15_suppl.8019 |
No items available.